CareCloud, Inc. (MTBC)

CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

CareCloud, Inc. (NASDAQ:CCLD ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - CEO Stephen Snyder - President Norman Roth - Interim CFO and Corporate Controller Conference Call Participants Allen Klee - Maxim Group Operator Ladies and gentlemen, welcome to the CareCloud Second Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.

CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to loss of $0.37 per share a year ago.

SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended June 30, 2024 before the market opens on Tuesday, August 13, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

SOMERSET, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the “Series A Preferred Shareholders”) of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of its' Series A Preferred Stock (the “Preferred Stock Proposal”). With approximately 20% of the shares of Series A Preferred Stock having already returned their proxies, 82% of these shares (up from 72% last week) are in favor of the changes recommended in the Preferred Stock Proposal.

Here is how CareCloud, Inc. (CCLD) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.

SOMERSET, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it has begun soliciting proxies from the holders (the “Series A Preferred Shareholders”) of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Preferred Stock Proposal”). Under the Preferred Stock Proposal, holders of Series A Preferred Stock would receive similar change of control protections to those afforded to holders of the Company's 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”). The future dividends of the Series A Preferred Stock would mirror that of the Series B Preferred Stock, and the Company would, going forward, have the right to exchange the shares of Series A Preferred Stock for shares of common stock at the liquidation preference value of $25 per share, plus any accrued and unpaid dividends.

Here is how CareCloud, Inc. (CCLD) and Context Therapeutics Inc. (CNTX) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CareCloud (CCLD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

CareCloud (CCLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Here is how CareCloud, Inc. (CCLD) and Heron Therapeutics (HRTX) have performed compared to their sector so far this year.

Focus on Enhancing Profitability and Further Streamlining Operations SOMERSET, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc.  (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the promotion of Crystal Williams as its new chief operating officer with the goal of further streamlining operations and supporting the Company's achievement of its profitability and free cash flow objectives.

SOMERSET, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended March 31, 2024 before the market opens on Tuesday, May 14, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

SOMERSET, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, is pleased to announce its participation in the 2024 Kansas MGMA Annual Conference, taking place from April 17-19 at the Wichita Marriott, Kansas. CareCloud will seize this opportunity to showcase its innovative solutions aimed at transforming revenue cycle management (RCM) and enhancing patient engagement within the healthcare industry.